期刊文献+

急诊选择性动脉溶栓治疗急性脑梗死的临床分析 被引量:7

Analysis of therapeutic time window and effect in acuter cerebral infarction treated with superselective intra-arterial thrombolytic therapy
下载PDF
导出
摘要 目的:评估急诊选择性动脉内溶栓(intra-arterial thrombolvsis,IAT)治疗急性缺血性脑梗死的治疗效果,探讨影响治疗时间窗和疗效的因素。方法:14例急性脑梗死患者均在CT检查、MRI+MRA及血管造影基础上接受超选择性动脉溶栓治疗,其中在6h以内溶栓11例,6~13h溶栓3例。统计各患者的侧支循环、TIMI分级及NIHSS评分情况。结果:脑血管造影发现8例患者存在较好侧支循环;溶栓后患者血管再通率为64.3%(9/14),TIMI分级达2~3级;9例成功再通患者中,7例(77.8%)神经功能显著恢复,1例再次大面积梗死;5例未再通患者中,3例临床症状改善不明显,死亡1例,仅1例(20%)神经功能恢复良好。14例患者中出现症状性颅内出血1例。结论:急诊动脉溶栓有效且安全可行,可根据MRI+MRA检查后的评价适当放宽溶栓的时间窗。溶栓前侧支循环、是否再通与预后密切相关。 Objective: To analyze the beginning time of treatment and the therapeutic effect of superselective intra - arterial thrombolysis in acute cerebral infarction. Methods: 14 patients with acute ischemic stroke examined by CT,MRI + MRA and DSA were received superselective intra - arterial thrombolytic therapy, of them, the thrombolytic therapy was done within 6h in 11 cases and 6 - 13h in 3 cases after onset of stroke. The collateral circulatian, recanalization rate and clinical prognosis were statisticed after therapy. Results: Collateral circulation was found in 8 cases. The rate of complete / partial recanalization just after infusion was 64.3 % (9/14). 9 cases' TIMI improved from 0 - 1 to 2 - 3 ,of them,7 cases (77.8%) had improved NIHSS; In the other 5 patients,which were not recanalizated,only 1 case (20%) had improved NIHSS,1 case died,3 cases had the same NIHSS after IAT. ICH was observed in 1 case. Conclusion:IAT is feasible and safe in the setting of acute stroke,the therapeutic time window is closely related to a lot of factors, it is not overall to be limited within 6 hours, MRI + MRA PWI and DWI mismatch might be a selective standard for the beginning time of treatment. Collateral circulation, recanalization were significantly associated with good clinical outcome.
出处 《中国民康医学》 2011年第4期394-396,共3页 Medical Journal of Chinese People’s Health
关键词 脑梗死 动脉溶栓 时间窗 MRI Cerebral infarction Intra - arterial thrombolvsis(IAT) Time window MRI
  • 相关文献

参考文献10

  • 1Del Zoppo DJ,Higashida RT,Furlan AJ,et al.Proact:a phase Ⅱ randowized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke[J].Stroke,1998,29(1):4-11.
  • 2Du W,Shao CM,Wang JL,et al.Intra-artery thombolytic therapy for acute ischemic cerebral infarction[J].J Interv Radiol,2004,13(3):231-233.
  • 3Wolpert SM,Bruckmann H,Greenlee R,et al.Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator[J].The rt-PA Acute Stoke Study Group.AJNR,1993,14:3-13.
  • 4Baron JC,von Kummer R,del Zoppo GJ.Treatment of acute ischemic stroke.Challenging the concept of a rigid and universal time window[J].Stroke,1995,26(14):2219-2221.
  • 5Furlan AJ.Emergency stroke intervention:current status[J].JVIR,1999,10(supl 2):47-48.
  • 6杨瑞民,程敬亮,张希中,李奋保,张铭秋.急性脑梗塞动脉内溶栓治疗时间窗选择与疗效分析[J].实用放射学杂志,2007,23(2):223-226. 被引量:19
  • 7Conner F,Remonda L,Mattle H,et al.Local intra-arterial thrombolysis in acute ischemic stroke[J].Stroke,1998,29(9):1894-1900.
  • 8国家"九五"攻关课题协作组.急性脑梗死六小时以内的静脉溶栓治疗[J].中华神经科杂志,2002,35(4):210-213. 被引量:371
  • 9The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.Tissue plasminogen activator for actue ischymic stroke[J].N Engl J Med,1995,333:1581-1587.
  • 10郭义坤,李焰生.急性脑梗死患者重组组织型纤溶酶原激活物静脉溶栓后脑出血[J].国际脑血管病杂志,2010,18(2):113-118. 被引量:10

二级参考文献59

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33009
  • 2The National Institute of Netrological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischernic stroke. N Engt J Med, 1995, 333: 1581-1587.
  • 3Hacke W, Donnan G, Fieschi C, et al.ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet, 2004, 363: 768 -774.
  • 4Reeves MJ, Arora S, Broderick JP, et al; Paul Coverdell Prototype Registries Writing Group. Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke, 2005, 36: 1232-1240.
  • 5The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke, 1997, 28: 2109- 2118.
  • 6Hacke W, Kaste M, Fieschi C, etal. Rardomised double-blind placebocoutrolled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS H). Second European-Australasian Acute Stroke Study Investigators. Lancet, 1998, 352: 1245-1251.
  • 7Kase CS, Furlan AJ, Wechsler LR, et al. Cerebral hemorrhage after intra-arterial tbrombolysis for ischemic stroke: the PROACT Ⅱ trial. Neurology, 2001,57: 1603-1610.
  • 8Lame V, von Kummer R R, Muller A, et al. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasrninogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS Ⅱ). Stroke, 2001,32: 438-441.
  • 9Clark WM, Wissman S, Atbers GW, et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA, 1999, 282: 2019-2026.
  • 10Hacke W, Kaste M, Bluhmki E, et al; ECASS Invesfigators. Thrombolysis with alteplase 3 to 45 hours after acute ischemic stroke. N Engl J Med, 2008, 359: 1317-1329.

共引文献397

同被引文献64

引证文献7

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部